SGLT2 Inhibitors and the Clinical Implications of Associated Weight Loss in Type 2 Diabetes: A Narrative Review
Crossref DOI link: https://doi.org/10.1007/s13300-021-01104-z
Published Online: 2021-07-09
Published Print: 2021-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Janež, Andrej
Fioretto, Paola
Text and Data Mining valid from 2021-07-09
Version of Record valid from 2021-07-09
Article History
Received: 15 April 2021
Accepted: 3 June 2021
First Online: 9 July 2021